These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14472314)

  • 1. Amphetamine, diethylpropion and tranylcypromin, a psychopharmacological study in the relation between structure and activity.
    MELANDER B; GLINIECKE G
    Acta Pharmacol Toxicol (Copenh); 1961; 18():239-48. PubMed ID: 14472314
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological action of 2-diethylaminopropiophenone. IV. Central sympathomimetic action].
    CAHEN R; MONTAGNE J; PESSONNIER J
    Therapie; 1962; 17():404-12. PubMed ID: 13875545
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological study of 2-diethylaminopropiophenone. III. Peripheral sympathomimetic action].
    CAHEN R; NADAUD J; TAURAND-AUBRON S; SAUTAI M
    Therapie; 1962; 17():395-403. PubMed ID: 13875547
    [No Abstract]   [Full Text] [Related]  

  • 4. Case of diethylpropion addiction.
    CLEIN LJ; BENADY DR
    Br Med J; 1962 Aug; 2(5302):456. PubMed ID: 13879863
    [No Abstract]   [Full Text] [Related]  

  • 5. [A METHOD OF THE "PHENAMINE STEREOTYPY" IN THE EVALUATION OF EFFECT OF VARIOUS SUBSTANCES ON CENTRAL ADRENERGIC PROCESSES].
    SHCHELKUNOV EL
    Farmakol Toksikol; 1964; 27():628-33. PubMed ID: 14264120
    [No Abstract]   [Full Text] [Related]  

  • 6. The biochemical pharmacology of abused drugs. I. Amphetamines, cocaine, and LSD.
    Caldwell J; Sever PS
    Clin Pharmacol Ther; 1974 Oct; 16(4):625-38. PubMed ID: 4607666
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacologic action of sympathomimetics].
    Vourc'h G
    Anesth Analg (Paris); 1969; 26(5):685-91. PubMed ID: 4391672
    [No Abstract]   [Full Text] [Related]  

  • 8. Structural activity relationships of a series of amines injected before and after monoamine oxidase inhibitor.
    Gatgounis J
    Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):412-20. PubMed ID: 5838346
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens.
    Laporte J; Jané F; Valdecasas FG
    J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of monoamine oxidase inhibitors with imipramine and similar drugs.
    HIMWICH WA
    Recent Adv Biol Psychiatry; 1961; 4():257-65. PubMed ID: 13907504
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlations between active eyelid closure and depletion of brain biogenic amines by respine.
    COSTA E; PSCHEIDT GR
    Proc Soc Exp Biol Med; 1961 Apr; 106():693-6. PubMed ID: 13695782
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the combined administration of imipramine and a monoamine oxidase inhibitor.
    HIMWICH WA; PETERSEN JC
    Am J Psychiatry; 1961 Apr; 117():928-9. PubMed ID: 13714420
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of monoamine oxidase inhibitors on the vasopressor actions of several sympathomimetic agents.
    KONO C; KANDA Z; SEKIYA A; SAJI E
    Nagoya J Med Sci; 1962 Jan; 24():159-70. PubMed ID: 14458230
    [No Abstract]   [Full Text] [Related]  

  • 14. [INTERFERENCE BY D-AMPHETAMINE IN THE ACTION OF SOME MONOAMINE OXIDASE INHIBITORS].
    FERRI S; MAFFEI-FACCIOLI A; ORNESI A; SCAMAZZO T
    Boll Soc Ital Biol Sper; 1963 Nov; 39():1381-4. PubMed ID: 14123621
    [No Abstract]   [Full Text] [Related]  

  • 15. CURRENT STATUS OF DRUG TREATMENT IN THE DEPRESSIVE STATE.
    SIEGLER PE
    Med Clin North Am; 1964 Mar; 48():483-500. PubMed ID: 14149246
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulant mechanisms of cathinones - effects of mephedrone and other cathinones on basal and electrically evoked dopamine efflux in rat accumbens brain slices.
    Opacka-Juffry J; Pinnell T; Patel N; Bevan M; Meintel M; Davidson C
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():122-30. PubMed ID: 24795175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some effects of tranylcypromine and trifluoperazine on electrocortical activity (EEG activation).
    LING GM
    Can Psychiatr Assoc J; 1962; 7(Suppl)():44-54. PubMed ID: 14465574
    [No Abstract]   [Full Text] [Related]  

  • 18. Further studies with tranylcypromine (monamine oxidase inhibitor) and its interaction with reserpine in rat brain.
    GREEN H; ERICKSON RW
    Arch Int Pharmacodyn Ther; 1962 Feb; 135():407-25. PubMed ID: 13901404
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuropharmacology of tranylcypromine and trifluoperazine.
    TEDESCHI RE; TEDESCHI DH; FELLOWS EJ
    Can Psychiatr Assoc J; 1962; 7(Suppl)():55-9. PubMed ID: 13920073
    [No Abstract]   [Full Text] [Related]  

  • 20. MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS IN ENHANCING AMPHETAMINE TOXICITY.
    BRITTAIN RT; JACK D; SPENCER PS
    J Pharm Pharmacol; 1964 Aug; 16():565-7. PubMed ID: 14223999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.